Rebuilding the Damaged Heart The Potential of Cytokines and Growth Factors in the Treatment of Ischemic Heart Disease

被引:89
作者
Beohar, Nirat [1 ,2 ]
Rapp, Jonathan [2 ,4 ]
Pandya, Sanjay [2 ]
Losordo, Douglas W. [1 ,2 ,3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA
[2] Northwestern Univ, Div Cardiol, Chicago, IL 60611 USA
[3] NW Mem Hosp, Bluhm Cardiovasc Inst, Program Cardiovasc Regenerat Med, Chicago, IL 60611 USA
[4] Ochsner Clin Fdn, Dept Cardiol, New Orleans, LA USA
基金
美国国家卫生研究院;
关键词
angiogenesis; cytokines; heart failure; regenerative medicine; COLONY-STIMULATING FACTOR; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; STEM-CELL MOBILIZATION; ENDOTHELIAL PROGENITOR CELLS; LEFT-VENTRICULAR FUNCTION; PLACEBO-CONTROLLED TRIAL; ANGIOGENIC GENE-THERAPY; DOUBLE-BLIND; GRANULOCYTE-MACROPHAGE;
D O I
10.1016/j.jacc.2010.05.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cytokine therapy promises to provide a noninvasive treatment option for ischemic heart disease. Cytokines are thought to influence angiogenesis directly via effects on endothelial cells or indirectly through progenitor cell-based mechanisms or by activating the expression of other angiogenic agents. Several cytokines mobilize progenitor cells from the bone marrow or are involved in the homing of mobilized cells to ischemic tissue. The recruited cells contribute to myocardial regeneration both as a structural component of the regenerating tissue and by secreting angiogenic or antiapoptotic factors, including cytokines. To date, randomized, controlled clinical trials have not reproduced the efficacy observed in pre-clinical and small-scale clinical investigations. Nevertheless, the list of promising cytokines continues to grow, and combinations of cytokines, with or without concurrent progenitor cell therapy, warrant further investigation. (J Am Coll Cardiol 2010; 56: 1287-97) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1287 / 1297
页数:11
相关论文
共 137 条
[1]   Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim:: the M.D. Anderson Cancer Center experience [J].
Anderlini, P ;
Donato, M ;
Chan, KW ;
Huh, YO ;
Gee, AP ;
Lauppe, MJ ;
Champlin, RE ;
Körbling, M .
TRANSFUSION, 1999, 39 (06) :555-560
[2]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[3]   Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].
Askari, AT ;
Unzek, S ;
Popovic, ZB ;
Goldman, CK ;
Forudi, F ;
Kiedrowski, M ;
Rovner, A ;
Ellis, SG ;
Thomas, JD ;
DiCorleto, PE ;
Topol, EJ ;
Penn, MS .
LANCET, 2003, 362 (9385) :697-703
[4]   Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders [J].
Autiero, M ;
Luttun, A ;
Tjwa, M ;
Carmeliet, P .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1356-1370
[5]   Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[6]   CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth [J].
Babic, AM ;
Kireeva, ML ;
Kolesnikova, TV ;
Lau, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6355-6360
[7]   Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium [J].
Balsam, LB ;
Wagers, AJ ;
Christensen, JL ;
Kofidis, T ;
Weissman, IL ;
Robbins, RC .
NATURE, 2004, 428 (6983) :668-673
[8]   ANGIOGENIC-INDUCED ENHANCEMENT OF COLLATERAL BLOOD-FLOW TO ISCHEMIC MYOCARDIUM BY VASCULAR ENDOTHELIAL GROWTH-FACTOR IN DOGS [J].
BANAI, S ;
JAKLITSCH, MT ;
SHOU, M ;
LAZAROUS, DF ;
SCHEINOWITZ, M ;
BIRO, S ;
EPSTEIN, SE ;
UNGER, EF .
CIRCULATION, 1994, 89 (05) :2183-2189
[9]   Human cardiac stem cells [J].
Bearzi, Claudia ;
Rota, Marcello ;
Hosoda, Toru ;
Tillmanns, Jochen ;
Nascirnbene, Angelo ;
De Angelis, Antonella ;
Yasuzawa-Amano, Saori ;
Trofimova, Irina ;
Siggins, Robert W. ;
LeCapitaine, Nicole ;
Cascapera, Stefano ;
Beltrami, Antonio P. ;
D'Alessandro, David A. ;
Zias, Elias ;
Quaini, Federico ;
Urbanek, Konrad ;
Michler, Robert E. ;
Bolli, Roberto ;
Kajstura, Jan ;
Leri, Annarosa ;
Anversa, Piero .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (35) :14068-14073
[10]   RETRACTED: Identification of a coronary vascular progenitor cell in the human heart (Retracted Article) [J].
Bearzi, Claudia ;
Leri, Annarosa ;
Lo Monaco, Francesco ;
Rota, Marcello ;
Gonzalez, Arantxa ;
Hosoda, Toru ;
Pepe, Martino ;
Qanud, Khaled ;
Ojaimi, Caroline ;
Bardelli, Silvana ;
D'Amario, Domenico ;
D'Alessandro, David A. ;
Michler, Robert E. ;
Dimmeler, Stefanie ;
Zeiher, Andreas M. ;
Urbanek, Konrad ;
Hintze, Thomas H. ;
Kajstura, Jan ;
Anversa, Piero .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (37) :15885-15890